Skip to Main Content

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

Conditions

Diseases of the Nervous System

Phase III

What is the purpose of this trial?

Brief Summary:

This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD.

  • Trial with
    NoNO Inc. Krembil Research Institute
  • Start Date
    11/18/2018
  • End Date
    03/31/2020
Trial Image

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    03/01/2019
  • Study HIC
    #2000022788